191 related articles for article (PubMed ID: 38673877)
1. Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism.
Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
[TBL] [Abstract][Full Text] [Related]
2. Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma.
Maaßen T; Vardanyan S; Brosig A; Merz H; Ranjbar M; Kakkassery V; Grisanti S; Tura A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302435
[TBL] [Abstract][Full Text] [Related]
3. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
Mergener S; Siveke JT; Peña-Llopis S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
[TBL] [Abstract][Full Text] [Related]
5. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
6. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
[TBL] [Abstract][Full Text] [Related]
7. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
[TBL] [Abstract][Full Text] [Related]
8. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
[TBL] [Abstract][Full Text] [Related]
9. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485
[TBL] [Abstract][Full Text] [Related]
10. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
12. Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Oláh G; Dobos N; Vámosi G; Szabó Z; Sipos É; Fodor K; Harda K; Schally AV; Halmos G
Eur J Pharm Sci; 2018 Oct; 123():371-376. PubMed ID: 30076951
[TBL] [Abstract][Full Text] [Related]
13. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
[TBL] [Abstract][Full Text] [Related]
14. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
[TBL] [Abstract][Full Text] [Related]
15. AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells.
Li M; Liu Y; Meng Y; Zhu Y
Cancer Biother Radiopharm; 2019 Dec; 34(10):626-633. PubMed ID: 31621397
[TBL] [Abstract][Full Text] [Related]
16. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
[TBL] [Abstract][Full Text] [Related]
17. [Pathological and molecular genetic characteristics in patients with extrabulbar growth of uveal melanoma].
Saakyan SV; Khoroshilova-Maslova IP; Tsygankov АY; Amiryan АG; Isaeva RТ
Arkh Patol; 2016; 78(4):20-26. PubMed ID: 27600778
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
